FA
Fred Aslan sold $422K of ARTV stock
Fred Aslan, Chief Executive Officer of Artiva Biotherapeutics, Inc. (ARTV), sold 61,696 shares of ARTV stock worth $422K, per an SEC Form 4 filed Oct 6, 2026.
It was an open-market sale.
The trade happened on Oct 5, 2026, 1 day before it was made public.
ARTV has moved -43.8% since the trade date, from $7.13 to $4.01 (Nov 13, 2026 close).
- Traded
- Oct 5, 2026
- Disclosed
- Oct 6, 2026
- Filing delay
- 1 day
- Price since
- -43.8%
- Role
- Chief Executive Officer
- Source
- SEC Form 4